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Scleractinian corals are themost basal eumetazoan taxon and
provide the biological and physical framework for coral reefs,
which are among the most diverse of all ecosystems. Over the
past three decades and coincident with climate change, these
phototrophic symbiotic organisms have been subject to
increasingly frequent and severe diseases, which are now geo-
graphically widespread and a major threat to these ecosys-
tems. Although coral immunity has been the subject of
increasing study, the available information remains fragmen-
tary, especially with respect to coral antimicrobial responses.
In this study, we characterized damicornin from Pocillopora
damicornis, the first scleractinian antimicrobial peptide
(AMP) to be reported. We found that its precursor has a seg-
mented organization comprising a signal peptide, an acidic
proregion, and the C-terminal AMP. The 40-residue AMP is
cationic, C-terminally amidated, and characterized by the
presence of six cysteine molecules joined by three intramo-
lecular disulfide bridges. Its cysteine array is common to
another AMP and toxins from cnidarians; this suggests a
common ancestor, as has been proposed for AMPs and toxins
from arthropods. Damicornin was active in vitro against
Gram-positive bacteria and the fungus Fusarium oxysporum.
Damicornin expression was studied using a combination of
immunohistochemistry, reverse phase HPLC, and quantita-
tive RT-PCR. Our data show that damicornin is constitutively
transcribed in ectodermal granular cells, where it is stored,
and further released in response to nonpathogenic immune
challenge. Damicornin gene expression was repressed by the
coral pathogenVibrio coralliilyticus. This is the first evidence
of AMP gene repression in a host-Vibrio interaction.
Scleractinian corals are the biological, ecological, and
physical framework of tropical coral reefs, which are among
the most diverse ecosystems on earth. Tropical coral reef
ecosystems commonly occur adjacent to developing coun-
tries and support major industries including food produc-
tion, tourism, and biotechnology development. However,
with global change, natural disturbances, and anthropogenic
pressures that are increasing in frequency and severity
(1–6), coral reefs are endangered. The reasons for this
alarming status are multiple and include increasing water
temperature, which disrupts symbiosis and leads to coral
bleaching, and anthropogenic pressures such as overfishing
that lead to ecosystem disequilibrium. Among impacts on
coral reefs, the incidence of coral disease appears to be
increasing in frequency and severity (1, 7). This phenome-
non appears to be aggravated by global warming, and it has
been suggested that high temperatures influence the out-
come of bacterial infections by lowering the resistance of the
coral to disease and/or increasing pathogen growth, infectiv-
ity, or virulence (8, 9). Increased virulence has been demon-
strated in the bacterium Vibrio coralliilyticus, where it leads
to bleaching and tissue lysis in Pocillopora damicornis (10),
and in Vibrio shiloi, which is the causative agent of bleaching
in Oculina patagonica (11). It has been shown that an
increase in temperature triggers bacteria adhesion and toxin
and enzyme production (12, 13).
Although the central role of Vibrio species in several coral
diseases has been widely documented, knowledge of the
effects of Vibrio infection on coral physiology/immunity is
rudimentary. One reason is the paucity of information on
coral immunology, particularly with respect to defenses
against infectious agents (1, 14). As for all invertebrates,
coral immunity is thought to rely on innate mechanisms
involving pattern recognition receptors and cellular and
humoral responses directed against infectious agents
(14–22).
There is virtually no information on the antimicrobial
response of scleractinians.However, several recent studies have
suggested the involvement of antibacterial agents. Thus, the
mucus of several species of scleractinians has been shown to
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have antibacterial properties (23–26), and in a recent study on
the transcriptomic response of P. damicornis to its specific
pathogenic bacterium V. coralliilyticus (27), we identified an
mRNA corresponding to a putative antimicrobial peptide
(AMP).3
We describe here the isolation and characterization of dami-
cornin, the first AMP reported from a scleractinian coral. We
report the structure of the damicornin precursor, its localiza-
tion in coral tissues, its antimicrobial spectrum against a panel
of microorganisms including its specific pathogenic bacterium
V. coralliilyticus, and its expression in corals confronted with
virulent and avirulent bacteria. Our results show that: (i) dami-
cornin has a cysteine array common to other cnidarian AMPs
and toxins; (ii) damicornin is expressed and released from coral
ectodermal cells exposed to a nonpathogenic stimulus; and (iii)
the gene for expression of damicornin is repressed concomi-
tantly with the invasion of host ectodermal cells by the coral
pathogen V. coralliilyticus.
EXPERIMENTAL PROCEDURES
Biological Material
The P. damicornis (Linnaeus, 1758) isolate used in this study
was collected from Lombock, Indonesia (CITES number
06832/VI/SATS/LN/2001), propagated, and maintained in
aquaria, as described previously (22). The filamentous fungus
Fusarium oxysporum and strains of the Gram-positive bacteria
Micrococcus luteus (A270), Bacillus megaterium (IBMC),
Staphylococcus aureus (SG511), Brevibacterium stationis (CIP
101282), andMicrobacteriummaritypicum (CIP 105733T) and
the Gram-negative bacteria Escherichia coli (SBS 363), Vibrio
aesturianus (CIP 109791), and Vibrio splendidus (CIP 107715)
were the same as used in a previous study (28). V. shiloi (CIP
107136) and V. coralliilyticus strain YB1 (CIP 107925) were
obtained from the Pasteur Institute (Collection de l’Institut
Pasteur).V. coralliilyticuswas used in biotic stress and infection
experiments with P. damicornis (29). For routine use V. coral-
liilyticus was cultured in 2216 Marine Broth medium (BD-
DIFCO 279110) at 30 °C under aerobic conditions with shaking
(150 rpm). During experimental procedures (see below), it was
used at the ambient coral maintenance temperature. Experi-
ments to determine which cells (host or symbiont) expressed
the candidate genes involved the use of three zooxanthellae
isolates; the origin of and culture conditions for the zooxanthel-
lae have been reported elsewhere (22).
Stress Protocol
The experiments were designed to investigate coral
responses to bacterial challenge (bacterial stress and bacterial
infection). Bacterial stress was induced by the addition of V.
coralliilyticus at 25 °C, whereas bacterial infection was induced
by the addition ofV. coralliilyticus under conditions of increas-
ing water temperature (from 25 to 32.5 °C), which activated
bacterial virulence. We recently reported that the bacterium
becomes virulent at a temperature of 28 °C (27).
Bacterial stress and infection treatments and appropriate
controls were established in four separate 120-liter tanks as
follows: (i) V. coralliilyticus added at a constant temperature of
25 °C (Cb); (ii) V. coralliilyticus added with a gradual tempera-
ture increase from 25 to 32.5 °C (Tb); (iii) a constant tempera-
ture of 25 °C without bacteria added (C); and (iv) a gradual
temperature increase from25 to 32.5 °C in the absence of added
bacteria (T). Nubbins of P. damicornis (fixed piece of coral of
10 g) were randomly placed in each experimental tank (n 
40/tank) and acclimatized at 25 °C for 2 weeks. Bacteria were
added to the Cb and Tb treatment tanks every 3 days by balnea-
tion (12). Briefly, this involved washing the bacteria twice in
filtered sea water (0.22 m) and adding the washed cells to the
tank to achieve a concentration of 103 cells/ml of tank water.
Water circulation ensured the homogenous distribution of bac-
teria in the tank. The cultures ofV. coralliilyticuswere grown at
25 °C for the Cb treatment and at the temperature correspond-
ing to that of the tank for Tb. For the Tb treatment and the T
control, the temperature was increased by 1.5 °C every 3 days,
beginning onday 3 (D3), until it reached 32.5 °C.ThreeP. dami-
cornis nubbins were randomly sampled from each tank every 3
days (D0, D3, D9, D12, D15, and D18).
The tank temperaturewas controlled using an aquariumheater
(600 W, Schego) connected to an electronic thermostat (Hobby
BiothermProfessional). Illuminationwas supplied at an irradiance
of 250 mol photon/m2/s (measured using a quantum meter;
QMSW-SS, Apogee Instruments Inc.) using metal halide lamps
(Iwasaki 6500 Kelvin, 400W) set to a 12-h light:12-h dark photo-
period. All other seawater parameters were held constant over
time in the tanks. A water pump (IDRA, 1300 liters/h) continu-
ously recycled the tank seawater at a rate of 10.8 tank volumes/h,
passing it through a biological filter and anAquavie protein skim-
mer (EPS 600). A proportion of the tank water (2%) was replaced
each day with natural filtered Mediterranean seawater heated to
25 °C.To avoid the growthof bacterial blooms, thewaterwas con-
tinuously treated using a UVC filter (JBL, AquaCristal Series II, 5
W). At each time of addition of V. coralliilyticus, all of the equip-
ment known to remove or kill bacteria (the protein skimmer and
the UVC filter) was inactivated for 4 h to allow the bacteria to
adhere to the coral tissues.
RNA Extraction and Complete Open Reading Frame
Characterization of the Putative AMP
RACE-PCR experiments were performed to characterize the
complete ORF of the putative AMP. Tissue extraction, total
RNA extraction, poly(A) purification, and RACE-PCR were
conducted using nonchallenged P. damicornis nubbin, as
described previously (22).
Quantitative RT-PCR Analyses
Quantitative RT-PCR (q-RT-PCR) was used to analyze the
expression profile of the putative AMP. Total RNA was
extracted, and 2.5 g was reverse transcribed using oligo(dT)
primers and the Superscript II enzyme (Invitrogen). The result-
ing cDNA products were purified using a Nucleotrap gel
extraction trial kit (Clontech), and q-RT-PCR was performed
3 Theabbreviationsusedare: AMP, antimicrobial peptide;MIC,minimal inhib-
itory concentration; Dn, day n; RACE, rapid amplification of cDNA ends;
q-RT-PCR, quantitative RT-PCR; Tricine, N-[2-hydroxy-1,1-bis(hydroxy-
methyl)ethyl]glycine; MBC, minimal bactericidal concentration; PB, poor
broth.
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using 2.5 l of purified cDNA (diluted 1:50 in water) in a total
volume of 10l containing 1 LightCycler 480 SYBRGreen I
MasterMix (Roche Applied Science) and 70 nM of each primer.
The primers, whichwere designed using the Light Cycler Probe
Design Software, version 1.0 (Roche Applied Science), are
shown in Table 1. Amplification was performed using a Light-
Cycler 480 system (Roche Applied Science) and the following
reaction conditions: activation of the Thermo-Start DNA
polymerase at 95 °C for 15 min, followed by 45 cycles of
denaturation at 95 °C for 30 s and annealing/extension at
60 °C for 1 min. Melting curve profiles were assayed to
ensure that a single product was amplified. Each run
included a positive cDNA control that was sampled at the
beginning of the experiment (D0) and also from each ampli-
fication plate; this positive control was also used as the cali-
brator sample, and blank controls (water) were included for
each primer pair. The PCR products were resolved by elec-
trophoresis, the bands were isolated directly from agarose
gels, and DNA was extracted using the gel extraction PCR
purification system V (Promega). The resulting q-RT-PCR
products were single-pass sequenced as described above.
For each reaction, the crossing point (Cp) was determined
using the second derivative max method applied by the Light-
Cycler Software, version 3.3 (Roche Applied Science). The PCR
efficiency (E) of each primer pair was calculated by determining
the slope of standard curves obtained from serial dilution anal-
ysis of the cDNAs pooled from all experimental samples, as
described previously (30). The individual q-RT-PCR efficiencies
for the targetor referencegeneswere calculatedusing the formula:
E 10(1/slope). The transcription level of the putative AMP was
normalized using the mean geometric transcription rate of three
reference genes encoding ribosomal proteins, obtained from P.
damicornis: 60 S ribosomal protein L22, 60 S ribosomal protein
L40A, and 60 S acidic ribosomal phosphoprotein P0 (GenBankTM
accession numbers HO112261, HO112283, and HO112666,
respectively). The stable expression status of these three genes
under nonstress, thermal stress, bacterial stress, and bacterial
infection conditionswas recently demonstrated (27). Thenormal-
ized relative quantities (NRQ) were calculated as described previ-
ously (31), using the equation,
NRQ 
Etarget
Cp,target
3
i  1
3
Erefi
Cp,refi
(Eq. 1)
where Etarget is the amplification efficiency of the gene of inter-
est; Eref is the amplification efficiency of the reference gene;
Cp, ref Cp, ref(calibrator) Cp, ref(sample); and Cp, target
Cp, target(calibrator) Cp, target(sample).
Identification of the Organism Expressing the Putative AMP
To determine which organism (host or symbiont) expressed
the putative AMP gene, cross-PCR experiments were per-
formed on DNA and RNA extracted from the holobiont (host
plus symbiont) and from pure cultured zooxanthellae, as
described previously (22). Briefly, PCR amplificationswere per-
formed with oligonucleotides amplifying the AMP, housekeep-
ing genes, the gene encoding the small ribosomal subunit RNA
of Symbiodinium spp. (32), and the cDNA encoding the major
basic nuclear protein (GenBankTM accession number
HO112459) of Symbiodinium spp. (Table 1).
Production of Synthetic Peptide and Antibodies
The putative peptide (ACADLRGKTFCRLFKSYCDKKGIR-
GRLMRDKCSYSCGCR-NH2) was chemically synthesized (5
mg; Genepep, Saint-Cle´ment de Rivie`re, France) in a C-termi-
nally amidated form, and the folding of the three disulfide
bondswas performed.TheHPLCpurity of the peptidewas 96%.
The synthetic peptide was used to assess the antimicrobial
activity of the putative AMP and to immunize New Zealand
rabbits, as described previously (33). Serum from nonimmu-
nized and immunized rabbits was collected 70 days after initial
injection and tested for the presence of specific Igs (antibody or
IgG) using ELISA (34) with uncoupled synthetic peptide
adsorbed onto MaxiSorpTM plates (Nunc). The IgG fraction
was purified using affinity chromatography (35), and antibody
specificity was tested by Western blot. Briefly, coral proteins
and the synthetic peptide were subjected to Tris-Tricine
(16.5%) gel electrophoresis and electroblotted onto a PVDF
membrane. To verify the specificity, the blots were probed with
preimmune and purified immune sera at a dilution of 1:1000.
The remainder of the procedure was performed as described
previously (36).
Immunolocalization Experiments
Tissues of P. damicornis from unstressed coral colonies or
from coral colonies stressed with nonvirulent bacteria were
processed following a procedure described elsewhere (37).
Thin sections (7m)of tissues embedded in Paraplast were cut,
mounted on silane-coated glass slides, and stored at 4 °C in a
dry atmosphere. The paraffin was removed from the sections,
which were incubated for 1 h at room temperature in a saturat-
ing medium containing 2% BSA, 0.2% teleostean gelatin, 0.05%
Tween 20, and 0.5% donkey serum in 0.05 mol/liter PBS at pH
7.4. The sections were then incubated overnight at 4 °C in a
moist chamber with the purified antibodies raised against syn-
thetic damicornin (85g/ml in saturatingmedium) or with the
depleted purified antibodies raised against synthetic dami-
cornin (depletion was performed by preincubating the purified
TABLE 1
Primers used for q-RT-PCR
Gene name Forward primer (53 3) Reverse primer (53 3)
Preprodamicornin AGTCCCAGAAAAGCGG GTGGGTAACATCGCGT
Major basic nuclear protein GGTACAGCAAACTGCG TTGGAAACGTCCGACC
60 S ribosomal protein L22 TGATGTGTCCATTGATCGTC CATAAGTAGTTTGTGCAGAGG
60 S ribosomal protein L40A CGACTGAGAGGAGGAGC CTCATTTGGACATTCCCGT
60 S acidic ribosomal phosphoprotein P0 GCTACTGTTGGGTAGCC CTCTCCATTCTCGTATGGT
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antibodies for 1 h at room temperaturewith the synthetic dami-
cornin). Excess antibodies were removed by repeated rinsing,
and the sections were then incubated for 1 h at room tempera-
ture with biotinylated anti-rabbit antibodies (secondary anti-
bodies; Amersham Biosciences RPN1004) diluted 1:250 in the
saturating medium. After incubation, the sections were rinsed
with PBS (pH 7.4) and stained for 15 min with streptavidin
AlexaFluor 568 (S11226;Molecular Probes) diluted 1:50 in PBS
and DAPI (D9542; Sigma; 2 g/ml). The sections were
mounted in Pro-Long antifade medium (P7481; Molecular
Probes) and observed using a confocal laser-scanning micro-
scope (TCSSP5; Leica).
Analysis of P. damicornis Tissues by Reverse Phase HPLC and
MALDI-TOFMS
To detect the native antimicrobial peptide in coral tissues,
nine coral nubbins (sampled from the Cb and C tanks) were
harvested, and the tissue was extracted using a water pick (800
ml of 0.2-m filtered seawater refrigerated at 4 °C). The
extracts were centrifuged at 3000  g for 10 min at 4 °C. The
extract supernatant was discarded, and the pellet was resus-
pended in 10 volumes of 2 M acetic acid and homogenized (15
strokes) using a Dounce homogenizer (100 m). The homoge-
nate was placed in a 4 °C water bath and sonicated (Vibra-
cellTM 75185, medium power, three pulses of 30 s), then stirred
over night at 4 °C, and finally centrifuged at 10,000  g for 20
min at 4 °C to remove cellular fragments. The supernatant was
immediately collected and prefractionated using a Sep-PakC18
Vac cartridge (Sep-Pac Vac 12cc;Waters Corporation). Briefly,
the Sep-Pak columnwaswashedusing acidifiedwaterwithTFA
(0.05%), and three successive elutions were performed with 10,
60, and 80% acetonitrile in acidified water. The fractions
obtained were lyophilized and reconstituted with 1 ml of acid-
ified water (0.05% TFA). The reconstituted extracts were cen-
trifuged for 20 min at maximum speed and 4 °C and tested for
antimicrobial activity as described below.
All of the HPLC purification steps were performed using a
Waters Breeze system (Waters 1525, binary HPLC pump)
equipped with a UV detector (Waters 2487, dual  absorbance
detector). The column effluent was monitored by UV absorp-
tion at 224 and 280 nm. Fractions were hand-collected and
tested for antimicrobial activity.
Aliquots (150 l) of Sep-Pak fractions with antimicrobial
activity were subjected to reverse phase HPLC using a Symme-
try C18 column (250 mm 4.6 mm;Waters). Elution was per-
formed with a linear gradient of 15–85% acetonitrile in acidi-
fied water over 70 min at a flow rate of 1 ml/min. Fractions
corresponding to absorbance peaks were collected in polypro-
pylene tubes, freeze dried, reconstituted in 0.1 ml of acidified
ultrapure water, and tested for antimicrobial activity as
described below. The active fraction was again subjected to
reverse phase HPLC using a Symmetry C8 column (150 mm
2.1 mm;Waters). Elution was performed with a linear gradient
of 45–55% acetonitrile in acidified water over 60 min at a flow
rate of 0.3 ml/min. Fractions corresponding to absorbance
peaks were collected in polypropylene tubes, freeze dried,
reconstituted in 0.03ml of acidified ultrapure water, and tested
for antimicrobial activity or submitted to MS analysis. The
dried active fraction or 20 g of synthetic peptide was resus-
pended in 10 l of pure water (ultra liquid chromatography/
mass spectrometry solvent; Biosolve).
MALDI-TOFmass measurements were carried out using an
UltraflexTM TOF/TOF mass spectrometer (Bruker Daltonics
GmbH, Bremen, Germany) at a maximum accelerating poten-
tial of 25 kV in positive mode and in either linear or reflectron
mode. Each sample (1 l) was co-crystallized on stainless steel
MALDI targets with 1l of 4-hydroxycinnamic acid (10mg/ml
of acetonitrile in aqueous 0.1% TFA, 7:3 v/v) using the dried
dropletmethod ofmatrix crystallization. External calibration of
the MALDI mass spectra was carried out using singly charged
monoisotopic peaks (Pepmix calibration standard; Bruker Dal-
tonics, Wissembourg, France).
The same molecules were also treated by tryptic digestion
prior toMALDI-TOFmass spectrometry. The tryptic digestion
was conducted directly on stainless steelMALDI targets. A 1-l
samplewas first reduced in 1l of a 2DTT solution (20mM in
NH4HCOO3, 50 mM) for 30 min at 55 °C in a moist chamber.
Secondly, alkylation was performed in the dark at room tem-
perature in a moist chamber by adding 1 l of a 2 iodoacet-
amide solution (110 mM, in NH4HCOO3, 50 mM) and incubat-
ing for 30 min. The protein samples were then digested by the
addition of 2 l of a trypsin (sequence grade; Promega, Char-
bonniere, France) solution (40 g/ml, reconstituted just prior
to use in 50mMNH4HCOO3) and incubation overnight at 37 °C
in a moist chamber. For MALDI-MS analysis, 1 l of 4-hy-
droxycinnamic acid was spotted onto the digest and dried.
Disulfide Bond Assignment of Damicornin
The experiments to establish the positions of the disulfide
bonds in the putative AMP were performed using a MALDI
LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scien-
tific, Bremen,Germany)with automatic gain control turned on.
The signal was optimized by adjusting the laser energy to 6–8
J. The default target values were used in all experiments. Both
MS and MS/MS experiments were acquired in centroid mode.
A 2-Damass window was used forMS/MS precursor selection.
Qualitative data were obtained using XcaliburTM software. The
Orbitrap analyzer was calibrated with the aid of a calibrated
peptidemixture (MSCAL4; Sigma-Aldrich) for optimization in
the mass range 200–4000.
Native peptide was digested with chymotrypsin without prior
reduction and alkylation. A sample (2l) was digestedwith 2l of
a chymotrypsin (sequencegrade;Promega,Charbonniere, France)
solution (0.04 g/l in 50 mM NH4HCOO3). Digestion was per-
formed overnight at 30 °C and spotted onto a stainless steel
MALDI target, asdescribedpreviously.Controls for chymotrypsin
digestion were conducted in water or with the synthetic peptide.
Antimicrobial Assays
Antibacterial Activity of HPLC Fractions—Following each
HPLC purification step, the antibacterial activity was assessed
using a liquid growth inhibition assay (38). Briefly, 10-l ali-
quots of the resuspended fractionswere incubated inmicrotiter
plates with 100 l of Luria-Bertani broth (LB) suspensions of
each ofM. luteus (startingA600, 0.001) andE. coli (startingA600,
0.001). Antibacterial activity was assayed by measurement of
Scleractinian AMP Immune Responses during Vibriosis
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bacterial growth (A600) following incubation for 12 h at 30 °C
forM. luteus and 37 °C for E. coli.
Determination of Minimal Bactericidal Concentration
(MBC)—Antibacterial activity was assayed against several bac-
teria. MBCs were determined as described previously (39). A
solution of 0.01% acetic acid and 0.2% BSAwas used to dissolve
and prepare a series of 2-fold dilutions of the synthetic peptide.
Aliquots (10 l) from each dilution were incubated in sterile
96-well polypropylene microtiter plates with 100 l of a sus-
pension of test bacteria (startingA600, 0.001) in poor broth (PB;
1% Bacto tryptone) or PB supplemented with NaCl (PB-NaCl;
15 g/liter) for marine bacteria or in marine broth 2216 for
Vibrio species. Bacterial growth was assessed after incubation
with agitation at 30 °C for 18 h or at 23 °C and 30 °C forV. shiloi
and V. coralliilyticus. The MBC was determined by plating the
contents of the first three wells having no visible bacterial
growth onto LB agar plates and incubating at 30 °C for 18 h. The
lowest concentration of synthetic peptide that prevented col-
ony formation was recorded as the MBC.
Determination of Minimal Inhibitory Concentration (MIC)—
MICs were determined using a liquid growth inhibition assay
based on a procedure described previously (40). Marine broth
2216 was used for Vibrio sp., PB-NaCl was used for other
marine bacteria, and PB was used for the remaining microor-
ganisms. Briefly, 10 l from each dilution of the synthetic pep-
tide was incubated in a microtiter plate with a 100-l suspen-
sion of each of the bacteria at a starting A600 of 0.001. TheMIC
was recorded as the lowest dilution inhibiting bacterial growth
(measured at A600) after incubation for 18 h at 30 °C or 30 °C
and 23 °C for V. shiloi and V. coralliilyticus.
Bactericidal Assay—Synthetic peptide (10l) at a concentra-
tion 10-fold higher than the MIC (12.5 M) was mixed with 90
l of an exponential phase PB culture of M. luteus (starting
A600, 0.01). Following incubation at 30 °C for 0, 1, 3, 10, and 30
min and 2, 6, and 24 h, aliquots (10l) were plated onto LB agar,
and the number of colony forming units was counted after
overnight incubation at 30 °C. Controls consisted of bacterial
culture incubated with 10 l of sterile water.
AntifungalAssay—Antifungal activitywasmonitored against
F. oxysporum using a liquid growth inhibition assay as
described previously (41).
Hemolysis Assay—A solution of 0.01% acetic acid and 0.2%
BSA was used to dissolve synthetic peptide (400 M) and pre-
pare a series of 2-fold dilutions. An aliquot (20 l) from each
dilutionwas added to 180l of a PBS (pH 7.4) solution contain-
ing sheep erythrocytes (5%, v/v). As a positive control for
hemolysis, 20 l of 10% Triton X-100 in PBS replaced the pep-
tide solution. The negative control consisted of 20 l of the
0.01% acetic acid and 0.2% BSA solution. Following incubation
for 2 h at 37 °C, the test solutions and controls were centrifuged
for 3min at 10,000 g. The absorbance of the supernatantswas
measured at 570 nm (AD340; Beckman Coulter), and the per-
centage hemolysis was calculated as % hemolysis (A570 sam-
pleA570 negative control)/(A570 positive controlA570 neg-
ative control) 100.
Statistical Analysis
Variations in gene expressionwere analyzed separately all along
the nonvirulent (Cb set) and virulent (Tb set) treatments using
Grubbs’ test (42, 43), which detects kinetic points that deviate sig-
nificantly from the others (i.e. outliers). Statistical tests were per-
formed using JMP software (SAS Institute, Inc.), and differences
were considered statistically significant at the 5% level.
RESULTS
Characterization of the Damicornin Precursor—In a study of
the transcriptomic response of P. damicornis to bacterial stress
or infection (27), we identified an expressed sequence tag with
amino acid sequence similarities to the prepro-aurelin gene
(GenBankTM accession number DQ837210), which encodes
the precursor of an AMP in the jellyfish Aurelia aurita
(BLASTX,E value 1.4; amino acid alignment shown in Fig. 1).
The complete cDNA, which was obtained by RACE-PCR (Fig.
2), consists of 751 nucleotides and contains an ORF encoding a
107-amino acid precursor sequence. This sequence has the
canonical prepropeptide organization of many AMP precur-
sors. It consists of a 22-amino acidN-terminal sequence (Met-1
to Ala-22), which is highly hydrophobic and corresponds to a
putative signal peptide (prepeptide), as predicted by the Sig-
nal3.0 software. This is followed by a highly acidic 45-amino
acid sequence (Ala-23 to Arg-67) with a calculated pI of 3.56.
Anionic amino acids (Asp and Glu) were found at 16 positions
in this proregion, which ends with a dibasic motif (Arg-66 to
Arg-67) consistent with the putative cleavage site. The C-ter-
minal sequence (Ala-68 toGly-107) corresponds to the putative
AMP and has an identical cysteine array and 37.3% amino acid
sequence identity with aurelin fromA. aurita (Fig. 1). The puta-
tive AMP of P. damicornis has several features of eukaryotic
AMPs: (i) a high content of basic amino acids (pI 9.64); (ii) six
Cys residues apparently involved in disulfide bond formation;
and (iii) a C-terminal Gly residue that could be a signal of ami-
dation (44). This putative AMP was termed damicornin, and
the complete cDNA sequence was submitted to GenBankTM
(accession number HQ825099).
FIGURE 1. Damicornin, aurelin, and anemonia toxins share the same cysteine array. The putative cleavage site is indicated by the double-ended arrow.
Conserved amino acids are highlighted in gray. The conserved cysteine array is highlighted in bold gray and outlined in black. The anemonia toxins ShK, BgK,
and HmK are produced by the anemones S. helianthus, B. granulifera, and H. magnifica, respectively. The essential dyad for toxins blocking voltage-gated K
channels is underlined. Anemonia toxin disulfide pairing (C1-C6, C2-C4, and C3-C5) is indicated under toxin sequences.
Scleractinian AMP Immune Responses during Vibriosis
22692 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 25•JUNE 24, 2011
 at CNRS, on June 20, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
Isolation, Biochemical Characterization, and Disulfide
Assignment of Native Damicornin—To demonstrate the pres-
ence of damicornin in coral tissues, we prepared an acidic
extract of corals that had beenmaintained at 25 °C and exposed
to V. coralliilyticus for 9 days. Unchallenged controls were also
prepared. Following an initial prefractionation step, which was
applied to each acidic extract using Sep-Pak cartridges (see
“Experimental Procedures”), only the 60% acetonitrile fraction
of the extract of V. coralliilyticus-exposed corals had antibac-
terial activity. This fraction was further separated using reverse
phase HPLC. All of the fractions were tested for activity against
M. luteus A270 (a sensitive Gram-positive strain) and E. coli
SBS 363 (a sensitive Gram-negative strain). Only one fraction
(Fig. 3A) was active, against M. luteus. This was eluted in 51%
acetonitrile and subjected to a further reverse phase HPLC sep-
aration step. Only one fraction was active, against M. luteus
(Fig. 3B). The MALDI mass spectrum of the active fraction
(acquired in positive linear mode) showed amajor ion atm/z
4492.740 (Fig. 4A), which corresponds to the calculated average
mass of damicornin (4492.35 Da) starting with an alanine resi-
due at position 68 of the damicornin preprosequence, ending
withC-terminal amidated arginine residue (resulting fromGly-
107 removal) and displaying oxidized cysteines. A peptide cor-
responding to this mature sequence was obtained by chemical
synthesis and had a mass identical to that of the active peptide,
as determined by MALDI-TOF MS (Fig. 4A). The active pep-
tide fromP. damicornis and the synthetic damicorninwere sub-
jected to tryptic digestion andmass spectrometry analysis. The
molecular mass fingerprints of both digests were similar. The
molecular mass fingerprints of both trypsic digests presented a
similar patternwith seven commonpeptides identified and corre-
sponding todamicornin (Fig. 4B).Altogether, thesedata showthat
damicornin is expressed in coral tissues and is processed as it was
hypothesized above. Damicornin contains six cysteine residues
involved in three intramolecular disulfide bonds and is C-termi-
nally amidated by removal of the C-terminal glycine.
For the determination of disulfide pairing between the six
cysteine residues of the damicornin, we first digest native pep-
tide with chymotrypsin, omitting the reduction alkylation steps
to preserve disulfide bridges. For three disulfide bridges, 15
possible disulfide bond pairing schemes can be predicted. The
peptidic fragments resulting from the chymotrypsin digest
were analyzed byMALDI LTQOrbitrapmass spectrometer. As
illustrated in supplemental Fig. S1A, the presence of pseudo-
molecular ions [MH] atm/z 1437.64, 1667.83, and 1766.71
were consistent with a possible pairing scheme C11 with C32,
C18 with C36 or C38, and C2 with C36 or C38. To confirm this
possible pairing scheme, ion fragmentation reactionswere con-
ducted by collision-induced dissociation. Fragmentation of ion
atm/z 1437.64 (supplemental Fig. S1B) confirmed the C11-C32
pairing. Because the C-terminal fragment SC36GC38R-NH2
obtained by chymotrypsin digestion includes two cysteines, the
assignment of the two other disulfide bridges was partial, and
results did not provide an unambiguous distinction between
bonding to C36 or to C38. Nevertheless, fragmentation of ions at
m/z 1766.71 and m/z 1667.84 (supplemental Fig. S1, C and D)
confirmed the pairing scheme C2-(C36 or C38) and C18-(C36 or
FIGURE 2. cDNA and deduced amino acid sequences of preprodami-
cornin. TheORF sequence is shown in capital letters. The expressed sequence
tag obtained from the subtractive subtraction hybridization library is high-
lighted in gray. The deduced amino acid sequence of the ORF is indicated
above the nucleotide sequence. The asterisk indicates the stop codon. The
arrow identifies the cleavage site of the signal peptide. The dibasic cleavage
site between the acidic N-terminal proregion and the cationic C-terminal
region is outlined in black. The damicornin active peptide is underlined in
black. The cysteine residues and glycine amidation signal are shown in bold.
FIGURE 3. Purification of damicornin from acidic extracts obtained from
challenged coral tissue. A, following prepurification by solid phase extrac-
tion, the material eluted from the fraction with 60% acetonitrile was loaded
onto a C18 column. In this HPLC step, elution was performed with a linear
gradient of 15 to 85% acetonitrile over 60 min at a flow rate of 1 ml/min.
Absorbance peaks were monitored at 224 nm. The fraction containing the
antimicrobial activity is indicated by an arrow. B, chromatogram from the last
reverse phase purification of damicornin on a C8 column; the arrow indicates
the fraction containing the purified antimicrobial peptide of interest.
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C38). The same cysteine connections were also obtained for the
synthetic damicornin (data not shown).
In addition, Fig. 1 gives the alignment of damicornin with the
anemonia potassium channel toxins ShK, BgK, andHmK (iden-
tified in the anemones Stichodactyla helianthus, Bunodosoma
granulifera, and Heteractis magnifica, respectively (45–47)).
This alignment shows that all of thesemolecules share the same
cysteine array. Note that the data obtained on damicornin cys-
teine connectivity (supplemental Fig. S1) were consistent with
those obtained for these anemonia toxins (given in Fig. 1).
Antimicrobial Activity of Damicornin—Because only small
amounts of purified native damicornin were obtained, the syn-
thetic peptide was used in antimicrobial assays. In liquid growth
inhibition assays, damicornin showed potent antifungal activity
against the filamentous fungus F. oxysporum, with anMIC of 1.25
M (Table 2). It was also active against Gram-positive bacteria.
The MBC was 2.5 M againstM. luteus and varied from 5 to
20 M against the other Gram-positive bacteria. However, no
activity was observed against most of the Gram-negative bacte-
ria, even at the highest concentration tested (20M); the excep-
tion was E. coli SBS 363 (MBC 20 M).
The bactericidal effect of synthetic damicornin against
Gram-positive bacteria was tested in kinetic experiments.
Damicornin was incubated with M. luteus at a concentration
10-fold higher than the MIC, and the inhibition of bacterial
growth was monitored over time. After 6 h, M. luteus had lost
the ability to grow on LB agar (Table 3). We therefore con-
cluded that damicornin was bactericidal againstM. luteus.
We found that sheep red blood cells were not affected by
exposure to damicornin at concentrations as high as 80 M for
24 h (data not shown). This indicates that damicornin has no
hemolytic activity.
Localization of Damicornin in Holobiont Tissues—The
sequence similarities between damicornin and the jellyfish
aurelin suggest that damicornin is expressed by coral cells and
not by the symbiont. To verify that the preprodamicornin
encoding gene is expressed by the cnidarians host, we devel-
oped cross-PCR experiments using DNA and cDNA extracted
from the holobiont (host plus symbiont) and frompure cultures
of Symbiodinium spp. clades B, C, and D (Fig. 5). The PCRs
were performed using primers amplifying (i) the damicornin
gene, (ii) housekeeping genes, (iii) small ribosomal subunit
RNA genes from Symbiodinium spp. (32), and (iv) the major
TABLE 2
Minimal inhibitory concentrationandminimal bactericidal concentra-
tion of damicornisn
MBC were determined by testing different concentrations of synthetic peptide in
liquid growth inhibition assays against different bacterial strains according to the
Hancock method. ND, not done.
Microorganisms MIC MBC
M M
Gram-positive bacteria
B. megaterium (souchier IBMC) 20 20
S. aureus (SG511) 5 20
M. luteus (A270) 1.25 2.5
B. stationis (CIP 101282)a 10 10
M. maritypicum (CIP 105733T)a 20 20
Gram-negative bacteria
E. coli (SBS 363) 10 20
V. aesturianus (CIP 109791)a 20 20
V. shiloi (CIP 107136)a,b 20 20
V. coralliilyticus strainYB1 (CIP 107925)a,b 20 20
V. splendidus (CIP 107715)a 20 20
Fungi
F. oxysporum 1.25 ND
a Marine bacteria.
b For these strains, the MIC and MBC were tested at either 23 or 30 °C. The re-
sults were the same at both temperatures.
TABLE 3
Bacteriolytic effect of damicornin onM. luteus
Time of incubation Control AMP
104 CFUml1 104 CFUml1
0 min 2.40 2.46
1 min 2.94 2.86
3 min 2.96 2.89
10 min 3.68 2.58
30 min 3.81 1.95
2 h 3.86 1.30
6 h 9.60 0.00
24 h 22.40 0.00
FIGURE 4. Identification of damicornin by mass spectrometry analysis.
A, superimposed linearmodeMALDImass spectra of purifieddamicornin and
synthetic peptide, showing amajor peak at 4492.740 Da. B, analysis of tryptic
digests of purifiedpeptide and synthetic peptidebyMALDI-TOFMS. Thepep-
tides identified by MS analysis are outlined and reported to the damicornin
sequence. The theoretical masses are shown, and the corresponding m/z
ratios are surrounded on each MS spectrum.
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basic nuclear protein gene of Symbiodinium spp. The dami-
cornin-specific primers gave amplicons for DNA and cDNA
from holobionts only (Fig. 5). In contrast, the small ribosomal
subunit RNA and major basic nuclear protein primers ampli-
fied DNA and cDNA from both holobiont and symbiont cul-
tures. As with the damicornin gene, the three q-RT-PCR refer-
ence genes (encoding the ribosomal proteins L22, L40A, and
P0) were only expressed in samples containing coral cells. This
indicates that the damicornin and reference genes are
expressed by coral cells.
Damicornin expression was monitored in coral tissue sec-
tions using antibodies raised against the synthetic peptide. The
antibody specificity was tested usingWestern blotting (supple-
mental Fig. S2). This experiment, performed on unstressed
coral, showed there was a molecular mass difference between
the synthetic damicornin and the band found in coral extracts
(10 kDa). This suggests that damicornin may be stored as a
precursor in coral tissues. The expected molecular mass of the
prodamicornin was 9.3 kDa. Because antibacterial activity was
detected by reverse phase HPLC fractionation of extracts of
coral tissue stressed by bacterial exposure, the localization of
damicornin was investigated in unstressed corals as well as
those subjected to bacterial stress. This enabled visual assess-
ment of the localization and concentration of damicornin in
corals of different immune status. To impose bacterial stress,
the corals were exposed to nonvirulent V. coralliilyticus for 9
days prior to tissues fixation. Similar results were obtained
under either condition. Corals are diploblastic animals com-
posed of two tissue types: oral and aboral (Fig. 6, panel A1).
Tissue sections stained with DAPI are shown in Fig. 6 (panel
A2). The reduced background obtained with this blue staining
of the nucleus highlights the two cellular layers constituting
each tissue type. The four different layers/epithelia can be easily
distinguished. Briefly, the oral layer is composed of oral ecto-
derm (exposed to the seawater) and oral endoderm (exposed to
the coelenteron or gastric cavity). The aboral layer is composed
of aboral endoderm (exposed to the coelenteron) and the aboral
ectoderm (in contact with the skeleton), which is also referred
to as the skeletogenic tissue. The ectoderm and endoderm (oral
and aboral) are separated by an acellular layer, the mesoglea.
Damicornin-specific antibodies specifically labeled cells in the
oral ectoderm (Fig. 6, panel C1). At higher magnification, the
staining was associated with cells containing intracellular gran-
ules (Fig. 6, panels C2 and C3). Controls treated with the
depleted antibody (i.e. antibodies preincubated with synthetic
damicornin) showed faint tissue autofluorescence but no spe-
cific labeling (Fig. 6, panels B1 andB2s), demonstrating that the
staining of the ectodermal granular cells was specific.
Damicornin Gene Expression following Bacterial Challenge—
The regulation of damicornin gene expression on exposure to
nonvirulent and virulent V. coralliilyticus was studied. Using
q-RT-PCR, we analyzed the relative amount of preprodami-
cornin transcripts in coral tissues 0, 3, 6, 9, 12, 15, and 18 days
after bacterial challenge. There was no significant variation in
transcript abundance after challenge with the nonvirulent bac-
teria (Fig. 7A), but large variation was evident after challenge
FIGURE 5. Thepreprodamicornin gene is expressedby the coral host. The
presence of preprodamicornin, the reference gene for q-RT-PCR, the small
ribosomal subunit RNA of the zooxanthellae (Zx ssRNA), and the gene corre-
sponding to themajor basic zooxanthellae nuclear proteinwere investigated
by PCR (using specific primers) on DNA and cDNA extracted from holobionts
(corals plus zooxanthellae) or from pure cultures of clade B, C, and D zooxan-
thellae. HgDNA, holobiont genomic DNA; ZgDNA, zooxanthellae genomic DNA;
HcDNA, holobiont cDNA; ZcDNA, zooxanthellae cDNA.
FIGURE 6. Immunolabeling of damicornin in ectodermal granular cells in
oral tissue. A1 and A2, bright field transmitted light image (A1) and an image
of the DAPI-stained nucleus (A2) showing the four tissue layers and the coel-
enteron (i.e. the gastric cavity) and their position in relation to the seawater
(SW) environment and the coral skeleton (SK). B1 and B2, control experiments
performedusing anti-damicornin antibodies thatwere preadsorbedwith the
synthetic peptide used for immunization. C1, C2, and C3, the labeled dami-
cornin appears bright orange. B2 and C2 are magnifications of B1 and C1,
respectively. Both show granular ectodermal cells (GC) with labeling (C2) and
without labeling in the control experiment (B2). C3 shows another area of the
oral ectoderm (OEc) with three labeled granular cells. Zx, zooxanthellae;OEn,
oral endoderm;Me, mesoglea.
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with the virulent V. coralliilyticus (Fig. 7B). Damicornin tran-
scripts markedly increased at day 6 (9.6-fold) and then declined
significantly from day 12 to the end of the experiment (more
than 44.5-fold at day 18 compared with day 0; Fig. 7B). This
strongly suggests that the coral pathogenV. coralliilyticus alters
expression of the damicornin gene.
DISCUSSION
This report is the first concerning characterization, purifica-
tion, and expression of an AMP from a scleractinian coral. It is
the most basal eumetazoan AMP characterized to date and the
only antimicrobial agent identified in a scleractinian coral. The
AMP (damicornin, from the coral P. damicornis) had antimi-
crobial activity against Gram-positive bacteria and the filamen-
tous fungus F. oxysporum but had little activity against Gram-
negative bacteria including V. coralliilyticus, a specific
pathogen of P. damicornis.
RACE-PCR experiments and MS-MS characterization of
native damicornin showed that it is a 39-residue cationic AMP
(theoretical pI  9.64) containing 11 basic residues. Its meas-
ured molecular mass (m/z  4492.740) indicates that dami-
cornin is folded by three intramolecular disulfide bridges
involving the six cysteine residues in its sequence and that it has
C-terminal amidation resulting from the removal of an end
glycine residue. AMPs folded by three intramolecular disulfide
bridges have been reported inmany invertebrate and vertebrate
species and often belong to the defensin superfamily (48).
According to cysteine pairing, animal defensins are classified
into four subfamilies, namely the vertebrate -, -, and -de-
fensins and the invertebrate defensins. The inclusion of dami-
cornin in these families appears inappropriate because of its
specific cysteine array. This also applies to AMPs from other
marine invertebrates (e.g. penaeidins) that contain three disul-
fide bridges and, like damicornin, have a cysteine array that
differs from that of invertebrate defensins (49). Despite this dif-
ference, damicornin shares several features in common with
invertebrate defensins: (i) it is particularly active against Gram-
positive bacteria and filamentous fungi but has limited activity
against Gram-negative bacteria; (ii) it is characterized by a lack of
hemolytic activity (48); and (iii) in terms of structural features, it
can alsohaveC-terminal amidation (50, 51).The latter is common
amongcationicAMPs; itmakes themmore resistant toproteolysis
and increases their net positive charge (49, 52–56).
From the completeORF obtained in the present study, dami-
cornin is generated from a 107-residue precursor that we have
termedpreprodamicornin. This includes in sequence a putative
signal peptide (22 amino acids), an anionic proregion (45 amino
acids), and a cationic damicornin sequence in the C-terminal
position (40 amino acids). Thus, from the structure of its pre-
cursor, damicornin is probably generated sequentially as fol-
lows: (i) the signal peptide translocates preprodamicornin to
the lumen of the rough endoplasmic reticulum and is cleaved
off by a signal peptidase; (ii) the anionic proregion of predami-
cornin is removed by proteolytic cleavage of theArg-67–Ala-68
bond by a processing enzyme that recognizes the dibasic motif
(Arg-Arg) located ahead of the observed cleavage site; and (iii)
theC-terminal extended glycine peptide substrate is hydroxylated
by a peptidylglycine--hydroxylating mono-oxygenase, and the
intermediate is cleavedby apeptidyl--hydroxyglycine--amidat-
ing lyase, which leads to the formation of the mature -amidated
damicornin and the release of a glyoxylate. The first two steps of
the process have been commonly reported in the maturation of
AMP precursors (57–60). The mechanism occurring during the
third stepwasdescribedbyKolhekar et al. (61) andhasbeen found
in the processing of various AMPs (49, 50).
Damicornin shares several key features with invertebrate
defensins: (i) it contains six cysteine residues involved in intra-
molecular disulfide bonds; (ii) it is mainly active against Gram-
positive bacteria and filamentous fungi; (iii) it has no hemolytic
activity; (iv) it has a classical precursor structure with a seg-
mented organization containing a signal peptide followed by
an anionic proregion and the cationic active peptide; (v) its
precursor is processed by mechanisms found for other
FIGURE 7. Disturbance of preprodamicornin expression following infection by virulent bacteria. The transcription rate of preprodamicornin was
measured by q-RT-PCR for samples at D0, D3, D6, D9, D12, D15, and D18 from the nonvirulent (A) and the virulent (B) treatments. The relative expression
was normalized using the geometric mean of three reference genes (normalized relative quantity, NRQ). The gray and black histograms represent the
relative expression of the coral preprodamicornin gene in the nonvirulent and virulent treatments, respectively. The bars represent the mean of
replicates, and the error bars represent the S.E. *, observations that deviated significantly (p 0.05) from others in the same treatment (the nonvirulent
and the virulent treatments).
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defensin precursors; and (vi) it has a C-terminal amidation
typical of several invertebrate defensins and other AMPs of
animal origin. However, damicornin is more similar (cys-
teine array and sequence similarities) to aurelin from the
jellyfish A. aurita (62). As with other invertebrate defensins
having the same cysteine array (the so-called CS motif),
including scorpion toxins (63, 64), damicornin and aurelin
have a common cysteine array with anemonia potassium
channel toxins of type 1 (Fig. 1). Aurelin has additional struc-
tural similarities with anemonia toxins: it has a Lys residue at
position 28 followed by an essential hydrophobic residue,
both of which have been shown to be crucial for toxin activ-
ity by blocking voltage-gated K channels (62, 65–67). This
essential dyad is not present in damicornin (Fig. 1). In addi-
tion, only damicornin has C-terminal amidation. These data
suggest that disulfide-containing AMPs (damicornin and
aurelin) and toxins from cnidarians originated from the
same molecular ancestor but have evolved independently to
acquire specific molecular features and function.
The results show that damicornin is expressed by coral oral
ectodermal cells and is locatedwithin intracellular granules. AMP
expression in granular epithelial cells has been reported in both
vertebrates (68–70) and invertebrates (71–73); this facilitates the
apical releaseofAMPinmucus and thus its participation inmuco-
sal defense and prevention of pathogen invasion.Our data suggest
that the release of damicornin could be part of the coral epithelial
defense.Whereasmatureandactivedamicorninwas isolated from
corals challengedwithnonvirulent bacteria, no antibacterial activ-
ity could be detected in unchallenged controls. However, dami-
cornin was expressed in both sets of animals, as evidenced by (i)
similar transcription levels and (ii) similar immunostaining of
ectodermal cell granules. This suggests that the inactive dami-
cornin precursor is stored in ectodermal cells and is activated by
post-translational processing upon release when triggered by an
immune challenge. Our Western blotting results support this
hypothesis; a band of10 kDa was detected by anti-damicornin
antibody in unstressed coral extracts (supplemental Fig. S2). This
band may correspond to prodamicornin, which has a theoretical
molecularmass of 9.3 kDa. The hypothesis that active damicornin
is matured and released in response to external signals is sup-
ported by previous studies showing the release of antibacterial
molecules immediately after injury in P. damicornis and Stylo-
phora pistillata (23, 24).
Amajor finding of this studywas that the expression of dami-
cornin was repressed in P. damicornis exposed to the virulent
pathogen V. coralliilyticus. After a transient (10-fold) increase
in damicornin transcript abundance during the first 6 days fol-
lowing infection, a dramatic decrease (50-fold) was observed
from days 9 to 18. In contrast, no transcriptional change was
observed when P. damicornis was exposed to the nonvirulent
bacterial state. In a recent study of infection byV. coralliilyticus
(27), we showed that the bacteria enter coral tissues 6 days after
challenge. This suggests that the first phase of infection
involves bacterial recognition by host cells, which triggers a
nonspecific inflammatory response that activates damicornin
gene transcription. In a second phase, following bacterial inva-
sion, the pathogen suppresses damicornin transcription. Simi-
lar mechanisms of immune suppression have been reported in
several intracellular bacteria including Shigella flexneri, which
suppresses the transcription of several genes encoding AMPs
following entry into intestinal cells (74). Although not reported
to directly affectAMPexpression, severalmarineVibrio species
have been shown to suppress or modulate host immune
defenses (75–79).
In conclusion, this report is the first to characterize a scleractin-
ian AMP (damicornin). Damicornin has several features in com-
mon with invertebrate defensins and shares a specific cysteine
array found in other cnidarian AMPs (aurelin from the jellyfishA.
aurita) and toxins produced (anemonia). Structural similarities
between AMPs and toxins have also been described for defensins
and toxins of arthropods. This strongly suggests that AMPs and
toxins have evolved from commonmolecular ancestors in diverse
phyla. Damicornin was shown to be expressed and released from
coral ectodermal cells in animals exposed to a nonpathogenic
stimulus. Conversely, damicornin gene expression was repressed
concomitantly with the entry of the coral pathogenV. coralliilyti-
cus into host ectodermal cells. This is the first evidence of AMP
gene repression in a host-Vibrio interaction. Future studieswill be
necessary to assesswhether this immune suppressionaccounts for
the success of the coral pathogen.
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Fig. S1. Damicornin disulphide bond assignment. Disulfide bond assignment was undertaken using a 
combination of endoprotease digestion and MS experiments. Panel (A) corresponds to MS spectrum 
obtained using a MALDI LTQ Orbitrap XL mass spectrometer. Interesting masses were associated 
with the putative peptides (boxes 1, 2 and 3). The various possible combinations of cysteine 
connectivity are given and reported on the damicornin sequence. The possible connectivities 
corresponding to each box number are reported (dotted lines) with the same number on the damicornin 
sequence. To confirm the identity of the putative peptide combination, MS/MS fragmentation of the 3 
molecules of interest was undertaken. Panel (B) shows the MS-MS analysis (1437.64 Da) of the 
peptide of C11RLF and MRDKC32SY (Box 1, panel A). Panel (C) shows the MS-MS analysis (1766.88 
Da) of the peptide of RDKC32SYSC36GC38R and AC2ADL (Box 3, panel A). Panel (D) shows the MS-
MS analysis (1667.83 Da) of the peptide of C18DKKGIRGRL and SC36GC38R (Box 2, panel A). "?" 
indicates that the cysteines implicated in the connectivity of 2 peptide could not be identified. 
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Fig. S2. Anti-damicornin antibody specificity tested by Western blotting. The specificity of the anti-
damicornin antibody was tested on coral protein extract and on the synthetic damicornin used for 
immunization, following Tris-tricine (16.5%) electrophoresis. Coral protein extract and synthetic 
damicornin were probed with the purified antibody and the pre-immune sera. 
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